Protalix BioTherapeutics, Inc. Stock TEL AVIV STOCK EXCHANGE
Stocks
PLX
US74365A3095
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 732.50 ILa | -.--% |
|
+3.29% | +69.68% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 188M 57.28B 165M 154M 141M 265M 17.99B 269M 1.82B 713M 8.89B 705M 689M 30.76B | P/E 2026 * |
11.9x | P/E 2027 * | 46.6x |
|---|---|---|---|---|---|
| Enterprise Value | 188M 57.28B 165M 154M 141M 265M 17.99B 269M 1.82B 713M 8.89B 705M 689M 30.76B | EV / Sales 2026 * |
2.4x | EV / Sales 2027 * | 2.78x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protalix BioTherapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 2019-06-29 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 2025-08-23 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 2024-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 2008-06-30 |
Aharon Schwartz
BRD | Director/Board Member | 82 | 2014-10-31 |
Dror Bashan
BRD | Director/Board Member | 59 | 2019-06-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +3.29% | - | - | 193M | |
| +1.93% | +6.43% | +50.20% | +168.28% | 1,068B | |
| +0.29% | +7.20% | +58.48% | +53.57% | 641B | |
| +2.45% | +3.88% | +38.32% | +76.82% | 454B | |
| +2.17% | +10.91% | +41.94% | +35.03% | 351B | |
| +1.46% | +5.93% | +40.44% | +43.69% | 299B | |
| +0.40% | +4.52% | +19.79% | +20.93% | 266B | |
| +2.73% | +2.26% | -25.81% | -36.98% | 220B | |
| +4.48% | +7.94% | +28.22% | +66.53% | 203B | |
| +2.91% | +0.83% | +15.59% | +75.56% | 162B | |
| Average | +1.55% | +2.76% | +29.69% | +55.94% | 407.04B | |
| Weighted average by Cap. | +1.08% | +2.85% | +39.07% | +81.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 78.3M 23.89B 68.77M 64.17M 58.94M 110M 7.5B 112M 759M 297M 3.71B 294M 288M 12.83B | 67.56M 20.62B 59.35M 55.37M 50.86M 95.3M 6.48B 96.86M 655M 256M 3.2B 254M 248M 11.07B |
| Net income | 15.72M 4.8B 13.81M 12.88M 11.84M 22.18M 1.51B 22.54M 152M 59.67M 745M 59.02M 57.74M 2.58B | 4.07M 1.24B 3.58M 3.34M 3.07M 5.75M 390M 5.84M 39.48M 15.46M 193M 15.29M 14.96M 667M |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
